Utah Medical Products, Inc.  

(Public, NASDAQ:UTMD)   Watch this stock  
Find more results for Epitome Inc
+0.09 (0.15%)
After Hours: 59.49 0.00 (0.00%)
Mar 2, 5:07PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 57.90 - 59.69
52 week 44.52 - 61.00
Open 59.50
Vol / Avg. 2,140.00/8,244.00
Mkt cap 228.49M
P/E 19.01
Div/yield 0.25/1.71
EPS 3.13
Shares 3.75M
Beta 0.35
Inst. own 66%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets - -
Return on average equity - -
Employees 177 -
CDP Score - -


7043 South 300 West
MIDVALE, UT 84047-1048
United States - Map
+1-801-5661200 (Phone)
+1-801-5667305 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Utah Medical Products, Inc. (UTMD), is in the business of producing medical devices that are, disposable and for hospital use. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices. UTMD's products are sold directly to end users in the United States domestic market by the Company's own direct sales representatives and independent manufacturers' representatives. In addition, some of UTMD's products are sold through specialty distributors, national hospital distribution companies and other medical device manufacturers. Internationally, products are sold directly to end users in the United Kingdom and Australia, and through other medical device companies and through independent medical products distributors in other countries.

Officers and directors

Kevin L. Cornwell Chairman of the Board, President, Chief Executive Officer and Secretary
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Paul O. Richins Chief Financial Officer, Chief Administrative Officer, Vice President, Treasurer, Assistant Secretary
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ernst G. Hoyer Lead Independent Director
Age: 76
Bio & Compensation  - Reuters
James H. Beeson M.D., Ph.D. Independent Director
Age: 72
Bio & Compensation  - Reuters
Barbara A. Payne Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters